© 2017 Dr Patricia Mugure ChegeThe neuronal loss observed in idiopathic Parkinson’s disease is primarily localized in the substantia nigra, part of the nigrostriatal pathway. This pathway regulates movement, therefore neurodegeneration results in the characteristic motor dysfunction associated with this disorder. This region is prone to iron accumulation in normal ageing. In Parkinson’s disease, the substantia nigra has been reported to have even more iron accumulation; one estimate puts the total iron increase at 176 % higher than healthy controls. We hypothesize that this abnormal accumulation of iron leads to dopaminergic neurodegeneration. We tested this hypothesis using Caenorhabditis elegans
Dopaminergic cell death in the substantia nigra (SN) is central to Parkinson’s disease (PD), but th...
BACKGROUND: The substantia nigra (SN) midbrain nucleus is constitutively iron rich. Iron levels elev...
The progression of Parkinson's disease (PD) seems to vary according to the disease stage, which grea...
It is now increasingly appreciated that glial cells play a critical role in the regulation of iron h...
International audienceAbstract In Parkinson’s disease, there is a progressive reduction in striatal ...
Dopamine metabolism, alpha-synuclein pathology, and iron homeostasis have all been implicated as pot...
© 2011 Dr. Scott AytonParkinson’s disease (PD) is a neurodegenerative disorder characterised by moto...
International audienceIn Parkinson’s disease, there is a progressive reduction in striatal dopaminer...
Both alpha-synuclein aggregation and iron deposits are neuropathological hallmarks of Parkinson’s di...
About 60 years ago, the discovery of a deficiency of dopamine in the nigro-striatal system led to a ...
Parkinson’s disease (PD) primarily results from loss of dopaminergic neurons in the substantia nigra...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor deficits accompanyin...
Abstract. Alpha synuclein pathology is widespread and found in diverse cell types in multiple system...
Abstract Parkinson’s disease (PD) is a neurodegenerative synucleinopathy characterized by the degene...
© 2016 The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain....
Dopaminergic cell death in the substantia nigra (SN) is central to Parkinson’s disease (PD), but th...
BACKGROUND: The substantia nigra (SN) midbrain nucleus is constitutively iron rich. Iron levels elev...
The progression of Parkinson's disease (PD) seems to vary according to the disease stage, which grea...
It is now increasingly appreciated that glial cells play a critical role in the regulation of iron h...
International audienceAbstract In Parkinson’s disease, there is a progressive reduction in striatal ...
Dopamine metabolism, alpha-synuclein pathology, and iron homeostasis have all been implicated as pot...
© 2011 Dr. Scott AytonParkinson’s disease (PD) is a neurodegenerative disorder characterised by moto...
International audienceIn Parkinson’s disease, there is a progressive reduction in striatal dopaminer...
Both alpha-synuclein aggregation and iron deposits are neuropathological hallmarks of Parkinson’s di...
About 60 years ago, the discovery of a deficiency of dopamine in the nigro-striatal system led to a ...
Parkinson’s disease (PD) primarily results from loss of dopaminergic neurons in the substantia nigra...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor deficits accompanyin...
Abstract. Alpha synuclein pathology is widespread and found in diverse cell types in multiple system...
Abstract Parkinson’s disease (PD) is a neurodegenerative synucleinopathy characterized by the degene...
© 2016 The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain....
Dopaminergic cell death in the substantia nigra (SN) is central to Parkinson’s disease (PD), but th...
BACKGROUND: The substantia nigra (SN) midbrain nucleus is constitutively iron rich. Iron levels elev...
The progression of Parkinson's disease (PD) seems to vary according to the disease stage, which grea...